Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;9(12):1974-1984.
doi: 10.1002/acn3.51690. Epub 2022 Oct 31.

Brain magnetic resonance imaging predictors in anti-N-methyl-D-aspartate receptor encephalitis

Affiliations

Brain magnetic resonance imaging predictors in anti-N-methyl-D-aspartate receptor encephalitis

Ying-Ying Zhao et al. Ann Clin Transl Neurol. 2022 Dec.

Abstract

Objective: Brain magnetic resonance imaging (MRI) findings in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis are nonspecific and rarely have obvious associations with clinical characteristics and outcomes. This study aimed to comprehensively describe the MRI features of patients with NMDAR encephalitis, examine their associations with clinical characteristics, and evaluate their predictive power for disease recurrence and prognosis.

Methods: We retrospectively extracted the clinical data and brain MRI findings of 144 patients with NMDAR encephalitis. Patients underwent a 2-year follow-up to assess disease outcomes. We evaluated the associations of brain MRI findings at the onset with clinical characteristics, recurrence, and prognosis.

Results: Initial MRI showed typical abnormalities in 65 patients (45.1%); of these, 34 (29.3%) developed recurrence and 10 (9.4%) had poor prognosis (mRS ≥3). Binary logistic regression analyses revealed that insula abnormalities were associated with acute seizure (odds ratio [OR] = 3.048, 95% confidence interval [CI]: 1.026-9.060) and white matter lesions were associated with cognitive impairment (OR = 2.730, 95% CI: 1.096-6.799). Risk factors for a poor 2-year prognosis included a higher number of brain MRI abnormalities (OR = 1.573, 95% CI: 1.129-2.192) and intensive care unit (ICU) admissions (OR = 15.312, 95% CI: 1.684-139.198). The risk factors for 2-year recurrence included abnormalities of the thalamus (HR = 3.780, 95% CI: 1.642-8.699).

Interpretations: Brain MRI features of patients with NMDAR encephalitis were associated with clinical manifestations, prognosis, and recurrence. Higher numbers of MRI abnormalities and ICU admissions were predictive of poor prognosis. Abnormalities of the thalamus constituted a recurrence-related risk factor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest in connection with this article.

Figures

Figure 1
Figure 1
Involvement of each brain region in 65 patients with abnormal brain MRI, where 1 (yellow) indicates abnormal MRI findings, and 0 (blue) indicates normal MRI findings. Some common combination patterns, such as lateral periventricular region + parietal lobe + frontal lobe, frontal lobe + parietal lobe + temporal lobe + insula, parietal lobe + temporal lobe + occipital lobe, and thalamus + basal ganglia + brain stem (among others) can be observed. Both outcome (Poor/Good) and recurrence (Yes/No) columns are included in the figure, with * representing lost to follow‐up.
Figure 2
Figure 2
Proportions of poor prognosis demonstrating an upward trend with respect to the number of MRI abnormalities.

Similar articles

Cited by

References

    1. Dalmau J, Graus F. Antibody‐mediated encephalitis. N Engl J Med. 2018;378:840‐851. doi:10.1056/NEJMra1708712 - DOI - PubMed
    1. Dalmau J, Armangué T, Planagumà J, et al. An update on anti‐NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18:1045‐1057. doi:10.1016/s1474-4422(19)30244-3 - DOI - PubMed
    1. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti‐NMDA‐receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091‐1098. doi:10.1016/s1474-4422(08)70224-2 - DOI - PMC - PubMed
    1. Peery HE, Day GS, Dunn S, et al. Anti‐NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev. 2012;11:863‐872. doi:10.1016/j.autrev.2012.03.001 - DOI - PubMed
    1. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391‐404. doi:10.1016/s1474-4422(15)00401-9 - DOI - PMC - PubMed

MeSH terms

Substances